CA
TNDM icon

Crewe Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Crewe Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed -$178 – 1011
2023
Q4 		$178 Buy
+6
New +$124 ﹤0.01% 360
2023
Q2 		– Sell
-18
Closed -$731 – 1003
2023
Q1 		$731 Hold
18
– – ﹤0.01% 771
2022
Q4 		$809 Hold
18
– – ﹤0.01% 940
2022
Q3 		$1K Hold
18
– – ﹤0.01% 1207
2022
Q2 		$1K Buy
+18
New +$1.48K ﹤0.01% 1108
2020
Q4 		– Sell
-8
Closed -$1K – 635
2020
Q3 		$1K Buy
+8
New +$841 ﹤0.01% 610

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Crewe Advisors's TNDM Position: Q1 2024 in Review

Crewe Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 6 shares — an estimated $178 sold.

Crewe Advisors first reported a position in TNDM in Q3 2020 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Crewe Advisors reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • Crewe Advisors sold 6 Tandem Diabetes Care shares in Q1 2024, an estimated $178.
  • Crewe Advisors first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 6 quarters.
  • Crewe Advisors's Tandem Diabetes Care position peaked at $1K in Q3 2022.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Crewe Advisors's 13F filing for Q1 2024, filed 14 May 2024.